Use your browser's back button to choose another title or click here for a New Search.

How to Get the Article

 Email CTN Library (free)

Journal subscriber access


Bookmark and Share




Menthol Cigarette Smoking Among Individuals in Treatment for Substance Use Disorders.

Addictive Behaviors 2018;80:135-141. [doi: 10.1016/j.addbeh.2018.01.015]

Noah R. Gubner, PhD (University of California, San Francisco), Denise D. Williams (University of California, San Francisco), Anna Pagano, PhD (Pacific Institute for Research and Evaluation), Barbara K. Campbell, PhD (Oregon Health & Science University, WS Node), Joseph R. Guydish, PhD, MPH (University of California, San Francisco).

There are higher rates of menthol cigarette smoking within certain population subgroups. Limited research has examined menthol use among individuals in treatment for substance use disorders (SUD), a population with a high prevalence of cigarette smoking, poor smoking cessation outcomes, and high tobacco disease burden.

To try to fill that research gap, this study collected survey data from 863 smokers sampled from 24 SUD treatment programs affiliated with the NIDA Clinical Trials Network (CTN) in the United States. Prevalence of menthol cigarette smoking was examined for the sample. Bivariate and multivariable analyses were used to examine demographic and tobacco use characteristics associated with menthol cigarette smoking.

Overall, the prevalence of menthol smoking among individuals in SUD treatment was 53.3%. Smoking menthol versus non-menthol cigarettes was associated with being female, African American, Hispanic/Latino, and lower odds of having a college degree. Controlling for demographic factors, menthol smokers were more likely to report marijuana as their primary drug compared to alcohol. Lastly, menthol smokers were more likely to report interest in getting help for quitting smoking, although they were not more likely to report making a past year quit attempt.

Conclusions: Use of menthol cigarettes was higher among smokers in SUD treatment than in general population smokers. Menthol cigarette smoking may contribute to tobacco use disparities among individuals with SUD. Regulatory policies targeting the manufacture, marketing, or sale of menthol cigarettes may benefit vulnerable populations, including smokers in SUD treatment. (Article (Peer-Reviewed), PDF, English, 2018)

Keywords: African Americans | CTN platform/ancillary study | Hispanics and Latinos | Marijuana | Menthol cigarettes | Minority groups | Smoking | Women | Addictive Behaviors (journal)

Document No: 1302, PMID: 29407684.

Submitted by CTN Dissemination Librarians, 2/15/2018.


Campbell, Barbara K. mail
Gubner, Noah R. mail
Guydish, Joseph R.
Pagano, Anna
Williams, Denise D.
dark blue line
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 2/2018 --
dark blue line